Ani Pharmaceuticals (ANIP) Dividends Paid - Common (2021 - 2025)
Ani Pharmaceuticals (ANIP) reported Dividends Paid - Common of $344000.0 for Q3 2025, down 15.27% on a YoY basis from $406000.0 in Q3 2024, and down 15.48% sequentially from $407000.0 in Q2 2025.
Ani Pharmaceuticals (ANIP) Dividends Paid - Common (2021 - 2025) Analysis & Trends
Ani Pharmaceuticals (ANIP) has 5 years of Dividends Paid - Common data on file, last reported at $344000.0 in Q3 2025.
- For the quarter ending Q3 2025, Dividends Paid - Common fell 15.27% year-over-year to $344000.0; the trailing twelve-month figure through Mar 2026 stood at $751000.0 (down 53.78% YoY), and the FY2025 full-year result was $1.2 million, down 28.8% from the prior year.
- Dividends Paid - Common slipped to $344000.0 in Q3 2025, from $407000.0 in the prior quarter.
- In the past five years, Dividends Paid - Common ranged from a high of $407000.0 in Q2 2022 to a low of $190000.0 in Q4 2021.
- A 5-year average of $388875.0 and a median of $406000.0 in 2022 frame the typical range for Dividends Paid - Common.
- Across the five-year window, Dividends Paid - Common surged 114.21% in 2022 and decreased 15.27% in 2025, its largest moves.
- Tracing ANIP's Dividends Paid - Common over 5 years: stood at $190000.0 in 2021, then soared by 114.21% to $407000.0 in 2022, then retreated by 0.25% to $406000.0 in 2023, then changed by 0.0% to $406000.0 in 2024, then fell by 15.27% to $344000.0 in 2025.
- Business Quant data shows ANIP's Dividends Paid - Common at $344000.0 in Q3 2025, $407000.0 in Q2 2025, and $406000.0 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 224.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.92 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 139.60 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Ani Pharmaceuticals | 1.64 Bn | 1.33 Bn | 143.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 344,000.00 |
| Sep 30, 2025 | 344,000.00 |
| Jun 30, 2025 | 407,000.00 |
| Jun 30, 2025 | 407,000.00 |
| Mar 31, 2025 | 406,000.00 |
| Mar 31, 2025 | 406,000.00 |
| Dec 31, 2024 | 406,000.00 |
| Dec 31, 2024 | 406,000.00 |
| Sep 30, 2024 | 406,000.00 |
| Sep 30, 2024 | 406,000.00 |
| Jun 30, 2024 | 407,000.00 |
| Jun 30, 2024 | 407,000.00 |
| Mar 31, 2024 | 406,000.00 |
| Mar 31, 2024 | 406,000.00 |
| Dec 31, 2023 | 406,000.00 |
| Dec 31, 2023 | 406,000.00 |
| Sep 30, 2023 | 406,000.00 |
| Sep 30, 2023 | 406,000.00 |
| Jun 30, 2023 | 407,000.00 |
| Jun 30, 2023 | 407,000.00 |